{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:53:33Z","timestamp":1767135213743,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd009497.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000}}],"reference-count":103,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009497.pub3","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T19:18:52Z","timestamp":1611861532000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Electrocoagulation for liver metastases"],"prefix":"10.1002","volume":"2021","author":[{"given":"Dawid","family":"Storman","sequence":"additional","affiliation":[{"name":"Chair of Epidemiology and Preventive Medicine, Department of Hygiene and Dietetics; Jagiellonian University Medical College; Krakow Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mateusz J","family":"Swierz","sequence":"additional","affiliation":[{"name":"Chair of Epidemiology and Preventive Medicine, Department of Hygiene and Dietetics; Jagiellonian University Medical College; Krakow Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P","family":"Riemsma","sequence":"additional","affiliation":[{"name":"Kleijnen Systematic Reviews Ltd; York UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Wolff","sequence":"additional","affiliation":[{"name":"Kleijnen Systematic Reviews Ltd; York UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerzy W","family":"Mitus","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology; The Maria Sklodowska-Curie Institute, Oncology Center, Krakow Branch; Department of Anatomy, Jagiellonian University Medical College; Krakow Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Pedziwiatr","sequence":"additional","affiliation":[{"name":"2nd Department of General Surgery; Jagiellonian University Medical College; Krakow Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos","family":"Kleijnen","sequence":"additional","affiliation":[{"name":"School for Public Health and Primary Care (CAPHRI), Maastricht University; Maastricht Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malgorzata M","family":"Bala","sequence":"additional","affiliation":[{"name":"Chair of Epidemiology and Preventive Medicine, Department of Hygiene and Dietetics; Jagiellonian University Medical College; Krakow Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,1,28]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD009497.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000217820","article-title":"Scavengers of oxygen-derived free radicals prolong survival in advanced colonic cancer. A new approach","volume":"14","author":"Salim","year":"1993","journal-title":"Tumor Biology"},{"issue":"2","key":"10.1002\/14651858.CD009497.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/02841868909111250","article-title":"Pharmacokinetics of intra-arterial mitomycin C with or without degradable starch microspheres (DSM) in the treatment of non-resectable liver cancer","volume":"28","author":"Andersson","year":"1989","journal-title":"Acta Oncologica"},{"issue":"1","key":"10.1002\/14651858.CD009497.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s00270-010-9845-7","article-title":"Embolization of the gastroduodenal artery before selective internal radiotherapy: a prospectively randomized trial comparing standard pushable coils with fibered interlock detachable coils","volume":"34","author":"Dudeck","year":"2011","journal-title":"Cardiovascular and Interventional Radiology"},{"issue":"6","key":"10.1002\/14651858.CD009497.pub3-BIB0004|cit4","first-page":"853.e15","article-title":"Trans arterial hepatic embolization (TACE) adopting polyvinyl alcohol microspheres preloaded with irinotecan (DEBIRI) versus systemic therapy (FOLFIRI) for liver metastases (LM) from colorectal cancer (CRC): a randomized study of efficacy, toxicity and quality of life","volume":"23","author":"Fiorentini","year":"2012","journal-title":"Journal of Vascular and Interventional Radiology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD009497.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1200\/jco.2012.30.4_suppl.587","article-title":"Hepatic arterial embolization adopting polyvinyl alcohol microspheres preloaded with irinotecan versus systemic chemotherapy for hepatic metastases from colorectal cancer: a phase III clinical research trial of activity and quality of life","volume":"30","author":"Fiorentini","year":"2012","journal-title":"Journal of Clinical Oncology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD009497.pub3-BIB0006|cit6","first-page":"15","article-title":"The ORCHESTRA trial: a phase III trial of adding tumor debulking to systemic therapy versus systemic therapy alone in (mCRC) multi-organ metastatic colorectal cancer","volume":"33","author":"Gootjes","year":"2015","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"10.1002\/14651858.CD009497.pub3-BIB0007|cit7","first-page":"406","article-title":"Locoregional versus systemic chemotherapy in metastatic colorectal cancer - efficacy of an additive immunotherapy with rubratin. A prospective randomized pilot study","volume":"14","author":"Holting","year":"1991","journal-title":"Onkologie"},{"issue":"6","key":"10.1002\/14651858.CD009497.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/1097-0142(19940915)74:6<1706::AID-CNCR2820740611>3.0.CO;2-J","article-title":"Utility of embolization or chemoembolization as second-line treatment in patients with advanced or recurrent colorectal carcinoma","volume":"74","author":"Martinelli","year":"1994","journal-title":"Cancer"},{"issue":"15 Suppl","key":"10.1002\/14651858.CD009497.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"TPS197","DOI":"10.1200\/jco.2010.28.15_suppl.tps197","article-title":"Yttrium microspheres with cetuximab plus irinotecan for patients with advanced colorectal cancer metastases to liver","volume":"28","author":"Murthy","year":"2010","journal-title":"Journal of Clinical Oncology"},{"issue":"Suppl","key":"10.1002\/14651858.CD009497.pub3-BIB0010|cit10","first-page":"18","article-title":"A phase III random assignment trial comparing percutaneous hepatic perfusion with melphalan (PHP-mel) to standard of care for patients with hepatic metastases from metastatic ocular or cutaneous melanoma","volume":"28","author":"Pingpank","year":"2010","journal-title":"Journal of Clinical Oncology"},{"issue":"Suppl","key":"10.1002\/14651858.CD009497.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1200\/jco.2010.28.15_suppl.3559","article-title":"Unexpected increased biliary toxicity when systemic bevacizumab is added to hepatic arterial infusion","volume":"15","author":"Power","year":"2010","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD009497.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/1097-0142(19890715)64:2<379::AID-CNCR2820640207>3.0.CO;2-8","article-title":"Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intraarterial versus continuous intraarterial\/intravenous therapy). Results of a controlled clinical trial","volume":"64","author":"Safi","year":"1989","journal-title":"Cancer"},{"issue":"9","key":"10.1002\/14651858.CD009497.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/1097-0142(19891101)64:9<1783::AID-CNCR2820640904>3.0.CO;2-Q","article-title":"Combined hepatic artery 5-fluorouracil and irradiation of liver metastases. A randomized study","volume":"64","author":"Wirtanen","year":"1989","journal-title":"Cancer"},{"issue":"3","key":"10.1002\/14651858.CD009497.pub3-BIB0014|cit14","first-page":"142","article-title":"Effects of hepatic artery chemotherapeutic embolization combined with perfusing LAK cells into hepatic artery after radical operation of liver cancer","volume":"8","author":"Xie","year":"2000","journal-title":"Zhonghua Gan Zang Bing Za Zhi\u00a0(Chinese Journal of Hepatology)"},{"key":"10.1002\/14651858.CD009497.pub3-BIB0015|cit15","unstructured":"ASERNIP-S Review Group Radiofrequency ablation of liver tumours (update and re-appraisal): a systematic review. Report no. 56 www.inahta.org\/upload\/Briefs_7\/06128_ASERNIPS_Radiofrequency_Ablation_Liver_Tumors.pdf"},{"issue":"10","key":"10.1002\/14651858.CD009497.pub3-BIB0016|cit16","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010163.pub2","article-title":"Microwave coagulation for liver metastases","author":"Bala","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD009497.pub3-BIB0017|cit17","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009058.pub3","article-title":"Cryotherapy for liver metastases","author":"Bala","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD009497.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/archsurg.135.6.657","article-title":"Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm","volume":"135","author":"Bilchik","year":"2000","journal-title":"Archives of Surgery"},{"issue":"1","key":"10.1002\/14651858.CD009497.pub3-BIB0019|cit19","first-page":"5","article-title":"Evidence-based guideline on management of colorectal liver metastases in the Netherlands","volume":"65","author":"Bipat","year":"2007","journal-title":"Netherlands Journal of Medicine"},{"key":"10.1002\/14651858.CD009497.pub3-BIB0020|cit20","volume-title":"TNM classification of malignant tumours","year":"2017"},{"issue":"8","key":"10.1002\/14651858.CD009497.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jclinepi.2007.10.007","article-title":"Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses","volume":"61","author":"Brok","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD009497.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/ije\/dyn188","article-title":"Apparently conclusive meta-analyses may be inconclusive - trial sequential analysis adjustment for random error risk in conclusive neonatal meta-analyses","volume":"38","author":"Brok","year":"2009","journal-title":"International Journal of Epidemiology"},{"issue":"20","key":"10.1002\/14651858.CD009497.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1001\/jama.291.20.2457","article-title":"Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles","volume":"291","author":"Chan","year":"2004","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD009497.pub3-BIB0024|cit24","first-page":"229","article-title":"The state of regional therapy in the management of metastatic colorectal cancer to the liver","volume":"16","author":"Cho","year":"2016","journal-title":"Expert\u00a0Review of\u00a0Anticancer\u00a0Therapy"},{"issue":"6","key":"10.1002\/14651858.CD009497.pub3-BIB0025|cit25","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006317.pub3","article-title":"Radiofrequency ablation in the treatment of liver metastases from colorectal cancer","author":"Cirocchi","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009497.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S1470-2045(04)01567-0","article-title":"Radiofrequency ablation of liver tumours: systematic review","volume":"5","author":"Decadt","year":"2004","journal-title":"Lancet Oncology"},{"issue":"3","key":"10.1002\/14651858.CD009497.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"21","key":"10.1002\/14651858.CD009497.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.3748\/wjg.v22.i21.4963","article-title":"Surgical dilemmas in the management of colorectal liver metastases: the role of timing","volume":"22","author":"Dimitroulis","year":"2016","journal-title":"World Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD009497.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/path.1700350303","article-title":"The classification of cancer of the rectum","volume":"35","author":"Dukes","year":"1932","journal-title":"The Journal of Pathology and Bacteriology"},{"issue":"7109","key":"10.1002\/14651858.CD009497.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD009497.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","article-title":"ESMO consensus guidelines for the management of patients with metastatic colorectal cancer","volume":"27","author":"Van Cutsem","year":"2016","journal-title":"Annals of Oncology"},{"issue":"6","key":"10.1002\/14651858.CD009497.pub3-BIB0032|cit32","first-page":"339","article-title":"A promising technique for liver cancer?","volume":"5","author":"Fong","year":"1999","journal-title":"Cancer Journal From Scientific American"},{"issue":"6","key":"10.1002\/14651858.CD009497.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jclinepi.2004.09.013","article-title":"Uncertainty method on best-worst case analysis in a binary meta-analysis","volume":"58","author":"Gamble","year":"2005","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD009497.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1365-2168.1999.01038.x","article-title":"Treatment of colorectal metastases","volume":"86","author":"Geoghegan","year":"1999","journal-title":"British Journal of Surgery"},{"key":"10.1002\/14651858.CD009497.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"6407","DOI":"10.2147\/OTT.S204340","article-title":"Microwave ablation compared with radiofrequency ablation for treatment of hepatocellular carcinoma and liver metastases: a systematic review and meta-analysis","volume":"12","author":"Glassberg","year":"2019","journal-title":"OncoTargets and Therapy"},{"issue":"4","key":"10.1002\/14651858.CD009497.pub3-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaoncol.2015.0735","article-title":"The global burden of cancer 2013","volume":"1","author":"Global Burden of Disease Cancer Collaboration","year":"2015","journal-title":"JAMA Oncology"},{"issue":"3","key":"10.1002\/14651858.CD009497.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"219","DOI":"10.7326\/0003-4819-149-3-200808050-00023","article-title":"Correction: reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"149","author":"Gluud","year":"2008","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD009497.pub3-BIB0038|cit38","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2015"},{"issue":"1","key":"10.1002\/14651858.CD009497.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2307\/2530643","article-title":"Estimation of a common effect parameter from sparse follow-up data","volume":"41","author":"Greenland","year":"1985","journal-title":"Biometrics"},{"issue":"12","key":"10.1002\/14651858.CD009497.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6. Rating the quality ofevidence-imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD009497.pub3-BIB0041|cit41","doi-asserted-by":"crossref","unstructured":"Higgins JPT Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019 Available from www.training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604"},{"key":"10.1002\/14651858.CD009497.pub3-BIB0042|cit42","doi-asserted-by":"crossref","unstructured":"Higgins JPT Li T Deeks JJ Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ,\u00a0 et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019 Available from www.training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604.ch6"},{"key":"10.1002\/14651858.CD009497.pub3-BIB0043|cit43","doi-asserted-by":"crossref","unstructured":"Higgins JPT Eldridge S Li T Chapter 23: Including variants on randomized trials. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ,\u00a0 et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019 Available from www.training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604.ch23"},{"key":"10.1002\/14651858.CD009497.pub3-BIB0044|cit44","doi-asserted-by":"crossref","unstructured":"Deeks JJ Higgins JPT Altman DG Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T,Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019 Available from www.training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604.ch10"},{"issue":"4","key":"10.1002\/14651858.CD009497.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1503\/cmaj.120744","article-title":"Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors","volume":"185","author":"Hrobjartsson","year":"2013","journal-title":"Canadian Medical Association Journal"},{"issue":"4","key":"10.1002\/14651858.CD009497.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/ije\/dyu115","article-title":"Bias due to lack of patient blinding in clinical trials. A systematic review of trials randomizing patients to blind and nonblind sub-studies","volume":"43","author":"Hrobjartsson","year":"2014","journal-title":"International Journal of Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD009497.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/ije\/dyt270","article-title":"Observer bias in randomized clinical trials with time-to-event outcomes: systematic review of trials with both blinded and non-blinded outcome assessors","volume":"43","author":"Hrobjartsson","year":"2014","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD009497.pub3-BIB0048|cit48","volume-title":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline. Guideline for Good Clinical Practice CFR & ICH Guidelines","volume":"1","author":"International Conference on Harmonisation Expert Working Group","year":"1997"},{"issue":"3","key":"10.1002\/14651858.CD009497.pub3-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"169","DOI":"10.14218\/JCTH.2015.00012","article-title":"Hepatobiliary tumors: update on diagnosis and management","volume":"3","author":"Kabbach","year":"2015","journal-title":"Journal of Clinical and Translational Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD009497.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3390\/jcm8030403","article-title":"Treatment of liver metastases from midgut neuroendocrine tumours: a systematic review and meta-analysis","volume":"8","author":"Kacmaz","year":"2019","journal-title":"Journal of Clinical Medicine"},{"issue":"11","key":"10.1002\/14651858.CD009497.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD009497.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.3389\/fonc.2019.01052","article-title":"Ablation or resection for colorectal liver metastases? A systematic review of the literature","volume":"9","author":"Kron","year":"2019","journal-title":"Frontiers in Oncology"},{"issue":"2","key":"10.1002\/14651858.CD009497.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/1098-2388(200009)19:2<135::AID-SSU6>3.0.CO;2-A","article-title":"Primary liver tumors","volume":"19","author":"Lau","year":"2000","journal-title":"Seminars in Surgical Oncology"},{"issue":"10","key":"10.1002\/14651858.CD009497.pub3-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.hpb.2018.04.001","article-title":"Intra-arterial therapies for unresectable and chemorefractory colorectal cancer liver metastases: a systematic review and meta-analysis","volume":"20","author":"Levy","year":"2018","journal-title":"HPB : the Official Journal of the International Hepato Pancreato Biliary Association"},{"issue":"2","key":"10.1002\/14651858.CD009497.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/jhep.2003.50047","article-title":"Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival","volume":"37","author":"Llovet","year":"2003","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"11","key":"10.1002\/14651858.CD009497.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/j.1365-2036.2006.02932.x","article-title":"Systematic review: evidence-based management of hepatocellular carcinoma - an updated analysis of randomized controlled trials","volume":"23","author":"Lopez","year":"2006","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"7","key":"10.1002\/14651858.CD009497.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta18070","article-title":"The clinical effectiveness and cost-effectiveness of ablative therapies in the management of liver metastases: systematic review and economic evaluation","volume":"18","author":"Loveman","year":"2014","journal-title":"Health Technology Assessment"},{"issue":"4","key":"10.1002\/14651858.CD009497.pub3-BIB0058|cit58","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"Journal of the National Cancer Institute"},{"issue":"4","key":"10.1002\/14651858.CD009497.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0168-8278(98)80162-1","article-title":"Treatment options in Western hepatocellular carcinoma: a prospective study of 224 patients","volume":"29","author":"Markovic","year":"1998","journal-title":"Journal of Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD009497.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/1098-2388(200009)19:2<177::AID-SSU9>3.0.CO;2-S","article-title":"Metastatic liver tumours","volume":"19","author":"McCarter","year":"2000","journal-title":"Seminars in Surgical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD009497.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/107327480601300105","article-title":"Resection of colorectal liver metastases: current perspectives","volume":"13","author":"McLoughlin","year":"2006","journal-title":"Cancer Control"},{"issue":"8","key":"10.1002\/14651858.CD009497.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s00270-018-1959-3","article-title":"Radiofrequency and microwave ablation compared to systemic chemotherapy and to partial hepatectomy in the treatment of colorectal liver metastases: a systematic review and meta-analysis","volume":"41","author":"Meijerink","year":"2018","journal-title":"Cardiovascular & Interventional Radiology"},{"key":"10.1002\/14651858.CD009497.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0168-8278(97)80462-X","article-title":"Liver resection or transplantation for hepatocellular carcinoma?","volume":"26","author":"Michel","year":"2002","journal-title":"Journal of Hepatology"},{"issue":"7","key":"10.1002\/14651858.CD009497.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jvir.2014.12.009","article-title":"Radiofrequency ablation for neuroendocrine liver metastases: a systematic review","volume":"26","author":"Mohan","year":"2015","journal-title":"Journal of Vascular & Interventional Radiology"},{"issue":"9128","key":"10.1002\/14651858.CD009497.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD009497.pub3-BIB0066|cit66","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004787.pub2","article-title":"Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma","author":"Oliveri","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"24","key":"10.1002\/14651858.CD009497.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD009497.pub3-BIB0068|cit68","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD009497.pub3-BIB0069|cit69","unstructured":"The Cochrane Collaboration Review Manager Web (RevMan Web) 2020"},{"key":"10.1002\/14651858.CD009497.pub3-BIB0070|cit70","unstructured":"Riemsma R Bala M Wolff R Kleijnen J Non-surgical ablation methods for primary malignant liver tumours and liver metastases www.zorginstituutnederland.nl\/publicaties\/standpunten\/2009\/05\/19\/verschillende-niet-chirurgische-locoregionale-interventies-bij-levertumoren-zijn-een-te-verzekeren-prestatie-rfa-nog-niet 31 302"},{"issue":"4","key":"10.1002\/14651858.CD009497.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1017\/S0266462303000552","article-title":"Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches","volume":"19","author":"Royle","year":"2003","journal-title":"International Journal of Technology Assessment in Health Care"},{"issue":"6","key":"10.1002\/14651858.CD009497.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-157-6-201209180-00537","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"157","author":"Savovi\u0107","year":"2012","journal-title":"Annals of Internal Medicine"},{"issue":"35","key":"10.1002\/14651858.CD009497.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16350","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"16","author":"Savovi\u0107","year":"2012","journal-title":"Health Technology Assessment"},{"issue":"5","key":"10.1002\/14651858.CD009497.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/aje\/kwx344","article-title":"Association between risk-of-bias assessments and results of randomized trials in Cochrane Reviews: The ROBES Meta-Epidemiologic Study","volume":"187","author":"Savovi\u0107","year":"2018","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD009497.pub3-BIB0075|cit75","first-page":"221-67","volume-title":"Biomedical Engineering in Gastrointestinal Surgery","author":"Schneider","year":"2017"},{"issue":"5","key":"10.1002\/14651858.CD009497.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD009497.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/01.cad.0000131140.12228.bb","article-title":"Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials-II: systemic and local non-embolization-based therapies in unresectable and advanced hepatocellular carcinoma","volume":"15","author":"Schwartz","year":"2004","journal-title":"Anti-Cancer Drugs"},{"issue":"3","key":"10.1002\/14651858.CD009497.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-2005-916282","article-title":"Management of hepatic metastases from colorectal cancer","volume":"18","author":"Sheth","year":"2005","journal-title":"Clinics in Colon and Rectal Surgery"},{"issue":"3","key":"10.1002\/14651858.CD009497.pub3-BIB0079|cit79","first-page":"145","article-title":"Colorectal cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"10.1002\/14651858.CD009497.pub3-BIB0080|cit80","doi-asserted-by":"publisher","first-page":"177-90","DOI":"10.1016\/b978-0-323-02752-6.50017-1","volume-title":"Surgery of the Skin","author":"Soon","year":"2005"},{"issue":"5","key":"10.1002\/14651858.CD009497.pub3-BIB0081|cit81","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012069.pub2","article-title":"Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies","author":"Storeb\u00f8","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD009497.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/archsurg.141.2.181","article-title":"Radiofrequency ablation of liver tumors. A systematic review","volume":"141","author":"Sutherland","year":"2006","journal-title":"Archives of Surgery"},{"issue":"3","key":"10.1002\/14651858.CD009497.pub3-BIB0083|cit83","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009498.pub4","article-title":"Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases","author":"Swierz","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD009497.pub3-BIB0084|cit84","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008717.pub3","article-title":"Percutaneous ethanol injection for liver metastases","author":"Swierz","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD009497.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/ije\/dyn179","article-title":"Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?","volume":"38","author":"Thorlund","year":"2009","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD009497.pub3-BIB0086|cit86","first-page":"57","article-title":"Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals","volume":"2","author":"Thorlund","year":"2010","journal-title":"Clinical Epidemiology"},{"key":"10.1002\/14651858.CD009497.pub3-BIB0087|cit87","unstructured":"Thorlund K Engstr\u00f8m J Wetterslev J Brok J Imberger G Gluud C User manual for Trial Sequential Analysis (TSA) ctu.dk\/tsa\/files\/tsa_manual.pdf 2011 (accessed 10 January 2020)"},{"key":"10.1002\/14651858.CD009497.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"key":"10.1002\/14651858.CD009497.pub3-BIB0089|cit89","unstructured":"Copenhagen Trial Unit TSA - Trial Sequential Analysis 2011"},{"issue":"8","key":"10.1002\/14651858.CD009497.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","article-title":"ESMO consensus guidelines for the management of patients with metastatic colorectal cancer","volume":"27","author":"Cervantes","year":"2016","journal-title":"Annals of Oncology"},{"issue":"41","key":"10.1002\/14651858.CD009497.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"11767","DOI":"10.3748\/wjg.v21.i41.11767","article-title":"Colorectal cancer: metastases to a single organ","volume":"21","author":"Vatandoust","year":"2015","journal-title":"World Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD009497.pub3-BIB0092|cit92","unstructured":"Viswanathan M Patnode CD Berkman ND Bass EB Chang S Hartling L Assessing the risk of bias in systematic reviews of health care interventions. In:\u00a0Methods Guide for Effectiveness and Comparative Effectiveness Reviews. Rockville (MD): Agency for Healthcare Research and Quality (US); 2008 - www.ncbi.nlm.nih.gov\/books\/NBK519366\/"},{"key":"10.1002\/14651858.CD009497.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/path.1711500308","article-title":"Hematogenous metastatic patterns in colonic carcinoma: an analysis of 1441 necropsies","volume":"140","author":"Weiss","year":"1986","journal-title":"Journal of Pathology"},{"issue":"1","key":"10.1002\/14651858.CD009497.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD009497.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2288-9-86","article-title":"Estimating required information size by quantifying diversity in a random-effects meta-analysis","volume":"9","author":"Wetterslev","year":"2009","journal-title":"BMC Medical Research Methodology"},{"issue":"1","key":"10.1002\/14651858.CD009497.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12874-017-0315-7","article-title":"Trial Sequential Analysis in systematic reviews with meta-analysis","volume":"17","author":"Wetterslev","year":"2017","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD009497.pub3-BIB0097|cit97","unstructured":"Colorectal Liver Metastases Surgical Challenges in the Management of Liver Disease.\u00a0Available at\u00a0www.intechopen.com\/books\/surgical-challenges-in-the-management-of-liver-disease\/colorectal-liver-metastases 10.5772\/intechopen.80558"},{"key":"10.1002\/14651858.CD009497.pub3-BIB0098|cit98","first-page":"285","article-title":"A retrospective study of patients with liver metastases from colorectal cancer","volume":"2","author":"Wood","year":"1976","journal-title":"Clinical Oncology"},{"issue":"7644","key":"10.1002\/14651858.CD009497.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"11","key":"10.1002\/14651858.CD009497.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1631\/jzus.B1700516","article-title":"Radiofrequency ablation versus hepatic resection for breast cancer liver metastasis: a systematic review and meta-analysis","volume":"19","author":"Xiao","year":"2018","journal-title":"Journal of Zhejiang University SCIENCE B"},{"issue":"10","key":"10.1002\/14651858.CD009497.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"e0139940","DOI":"10.1371\/journal.pone.0139940","article-title":"Comparative effectiveness of hepatic artery based therapies for unresectable colorectal liver metastases: a meta-analysis","volume":"10","author":"Zacharias","year":"2015","journal-title":"PloS one"},{"issue":"12","key":"10.1002\/14651858.CD009497.pub3-BIB0102|cit102","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009497","article-title":"Electro-coagulation for liver metastases","author":"Riemsma","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD009497.pub3-BIB0103|cit103","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009497.pub2","article-title":"Electro-coagulation for liver metastases","author":"Riemsma","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T04:19:15Z","timestamp":1639196355000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009497.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Hepato-Biliary Group","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,1,28]]},"references-count":103,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009497.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,28]]}}}